Gillian C. Ivers-Read
Overview
Gillian C. Ivers-Read received an average of $2M in total compensation, including $412K in salary, at Clovis Oncology from 2010 to 2021.
2021Clovis OncologyEVP and Chief Regulatory Officer
2020Clovis OncologyEVP and Chief Regulatory Officer
2019Clovis OncologyEVP and Chief Regulatory Officer
2018Clovis OncologyEVP and Chief Regulatory Officer
2017Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
2016Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
2015Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
2014Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
2013Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
2012Clovis OncologyEVP of Technical Operations and Chief Regulatory Officer
Source: SEC filings on April 27, 2022, April 28, 2021, April 24, 2020, April 26, 2019, April 27, 2018, April 26, 2017, April 27, 2016, April 30, 2015, and April 29, 2013.
Related executives
We found eight more executives who work or worked at Clovis Oncology.
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
Lindsey Rolfe
Clovis Oncology
Chief Medical Officer
Paul Gross
Clovis Oncology
General Counsel
Daniel Muehl
Clovis Oncology
Chief Financial Officer
C Hooks
Clovis Oncology
Former Senior VP and Chief Commercial Officer
Erle Mast
Clovis Oncology
Chief Financial Officer
Andrew Allen
Clovis Oncology
Chief Medical Officer
Steven Hoerter
Clovis Oncology
EVP and Chief Commercial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019